GESTAGENES IN THE TREATMENT of ENDOMETRIOSIS: EFFICIENCY, SAFETY, BIOEQUIVALENCE, TRANSFERABILITY

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Endometriosis is a chronic disease that requires long-term treatment, the goal of which is effectively use drugs and avoids repeated surgical interventions. The quality of patients'life depends on the varying degrees of symptoms such as pelvic pain, dyspareunia, dysmenorrhea. Endometriosis causes infertility and perinatal complications.The symptoms of endometriosis often affect psychological and social well-being, and threaten the relationships, sexuality and mental health of women.Women with endometriosis have high levels of anxiety, depression, and other psychiatric disorders that can aggravate the severity of their pain. The existing statistics on the endometriosis incidence is underestimated given the diagnostic difficulties. So far, there are no final, only generally an accepted method of treating endometriosis, and in most cases, treatment is only eliminates the symptoms.Today, it is desirable to take a conservative approach to treatment, avoiding surgery, and hormone therapy is recommended to relieve pain associated with endometriosis. An individual approach is important in the management of patients with endometriosis, taking into account the reproductive plans and needs of woman. Medical treatment methods should be used as much as possible, for example, dienogest 2 mg (in particular, Savis drug). Dienogest is a derivative of 19-nortestosterone, which has an antiproliferative effect on the endometriosis foci. Savis is a drug specially formulated for the endometriosis treatment. Savis may be prescribed to relieve symptoms before and after surgery to prevent relapse.The safety profile of dienogest has been studied and data is constantly accumulating, given the popularity of its prescription. The effectiveness of dienogest should be assessed primarily by its effect on pain and quality of life, on maintaining fertility, and on the possibility of avoiding or postponing surgery.This is important for various forms of endometriosis: endometriomas, extragenital endometriosis, adenomyosis.

Cite

CITATION STYLE

APA

Hryhorenko, A. M. (2021). GESTAGENES IN THE TREATMENT of ENDOMETRIOSIS: EFFICIENCY, SAFETY, BIOEQUIVALENCE, TRANSFERABILITY. Reproductive Endocrinology, (61), 72–75. https://doi.org/10.18370/2309-4117.2021.61.72-75

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free